Molecular Diagnostics

Novel Methylated DNA Markers Assay Detects Cancer
An estimated 56,770 people will be diagnosed with pancreatic cancer in the U.S. in 2019, and more than 45,750 will die from the disease. Pancreatic cancer is the third leading cause of cancer-related deaths in the U.S. and is expected to become the second leading cause by 2020. More...20 Jun 2019
Biomarker Found for Celiac Patients on Gluten-Free Diet
Celiac disease is a complex condition, routinely treated by means of a strict gluten-free diet (GFD). One of the diagnostic challenges of this disease is that patients need to be consuming gluten so that a correct diagnosis by means of endoscopy can be made. More...19 Jun 2019

Study Results Validate Use of Tumor Markers to Treat Metastatic Cancer
Promising results obtained in a recently conducted pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. More...17 Jun 2019




Custom NanoString Assay Detects Bowel Cancer Subtypes
Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide. The median overall survival of metastatic (m)CRC patients with unresectable disease remains around 24 months with standard chemotherapies. More...13 Jun 2019
In Other News
Genetic Familial Hypercholesterolemia Prevalent in Premature CVD
Invasive Pulmonary Aspergillosis Diagnosed by Molecular Test
Sequencing Study Links DNA Alterations to Type 2 Diabetes
FDA Clears CT/NG Assays for Extragenital Testing
Genomic Analysis Uncovers Differences in Liver Cancer Subtypes
Oral Bacteria Found in Cerebral Emboli of Stroke Patients
CtDNA Forecasts Non-Metastatic Colorectal Cancer Recurrence
Stem Cell Transplantation Increases Risk of Infection-Related Mortality
Stem Cell Transplantation Increases Risk of Infection-Related Mortality
Liquid Biopsy Identifies Mutations Predicting Ovarian Cancer Treatment Response
Blood Test Measures Effectiveness of Aggressive Cancer Treatments
Rapid Assay Detects Pyrazinamide-Resistant Tuberculosis
Genomic Data Affects Prognosis of Advanced Prostate Cancer
Assay Stratifies Esophageal Cancer Patients for Treatment
Protein Panel Accurately Differentiates Forms of Ovarian Tumors
Clinical Trial Highlights Poor Prognosis for Bladder Cancer Patients
Prostate Cancer Severity Indicated by Location and Concentration of Syntaphilin
Clinical Validation Bolsters Liquid Biopsy Evidence Base
Serum HBV RNA Quantification Monitors Chronic Hepatitis B Infection
Breast Cancer Test Determines Most Effective Treatment
Urine Test Could Prevent Cervical Cancer
Biomarker Predicts Appropriate Immunotherapy for Cancer Patients
Oral HPV-DNA Persists after Oropharyngeal Cancer Treatment
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







